期刊文献+

^(212)Pb-^(212)Bi发生器的分离研究 被引量:5

SEPARATION STUDIES OF ^(212)Pb-^( 212)Bi RADIONUCLIDIC GENERATOR
下载PDF
导出
摘要 研究了Th^(4+)在水合钛酸钠上的吸附行为和Pb(+2),Bi^(3+)在离子交换树脂上的吸附、解吸,并用小柱实验从^(228)Th里分离出^(212)Pb,^(212)Bi,从^(212)Pb里分离出^(212)Bi,测量了^(212)Bi的α和γ谱,按照所研究的分离方法可制成用于放射免疫治疗的^(212)Pb-^(212)Bi发生器。 Adsorption behavior of Th4+ ions on hydrous sodium titanate (STB) and separation conditions of Pb2+ and Bi3+ on cation- and anion-exchange have been studied in inorganic acid medium of low acidity. Distribution coefficient for Th4 + ions on STB amounts to 106 and quantitative separation of Pb-Bi pair can be obtained. Radiochemical separations of 212Pb from 228Th and 212Bi from 212Pb have been carried out using column experiment. And, from α- and γ-spectra of the eluate samples decontamination factor for 228Th and radionuclidic purity of 212Bi product are determined to be 104 and 97.3%, respectively. The experimental results can be used to prepare 212Pb- 212Bi generator for nuclear medicine therapy.
出处 《核化学与放射化学》 CAS CSCD 北大核心 1991年第2期71-77,81,共8页 Journal of Nuclear and Radiochemistry
基金 国家自然科学基金
关键词 ^212Pb ^212Bi ^228Th 同位素 (228)~Th, (212)~Pb, (212)~Bi, α-radioactivity, Radionuclidic generator.
  • 相关文献

同被引文献52

  • 1昝亮彪,刘宁,杨远友,金建南.α核素用于肿瘤靶向治疗研究的进展[J].核技术,2006,29(4):279-285. 被引量:5
  • 2Hoefnagel C A. Radionuclide therapy o{ tumors: general aspects and considerations[J]. Int J Biol Markers, 1993, 8(3): 172-179.
  • 3Breitz H B. Dosimetric considerations for radio- immunotherapy[J]. Diagn Oncol, 1993, 3(4): 209-215.
  • 4Allen B J, Blagojevic N. and 13 emitting radiol- anthanides in targeted cancer therapy: the poten- tim role of 149Tb[J]. Nucl Med Commun, 1996, 17(1) : 40-47.
  • 5Larsen R H, Murud K M, Akabani G, et al. Has high in vivo stability and bone accumulation of 2u At-and 131i_labeled bisphosphonates [ J ]. Nuclear Medicine ,1999, 40(7): 1 197-1 203.
  • 6Sgouros G. Alpha-particles for targeted therapy [J]. AdvDrugDelivRev, 2008, 60(12): 1 402- 1 406.
  • 7Larsen R H, Bruland OS. Targeting of skeletal metastases by the alpha-emitter Radium-223 [C/ OL]. http://www, bruland, info/PDF/195 202. pdf.
  • 8Parker C, Nilsson S, Heinrich D, et al. Alpha emitter radium-223 and survival in metastatic prostate cancer[J]. N Engl J Med, 2013, 369 (3): 213 223.
  • 9Larsen R H, Henriksen G. Preparation of ra- dium-223, physically accepted preparation and kit:Norway, CA2358498Al[P]. 1999 12-17.
  • 10Nilsson S, Larsen R H, Fossa S D, eta[. First clinical experience with alpha-emitting radium- 223 in the treatment of skeletal metastase [J ]. Clin Cancer Res, 2005, 11(12): 4 451-4 459.

引证文献5

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部